UC Davis Health at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
UC Davis Health brings 9 presentations to IDWeek 2026 in Washington. Its program centres on clinical mycology, from preventing fungal infections in immunocompromised patients to treating resistant molds. One study collects long-term follow-up on patients given olorofim for invasive fungal infections when no suitable alternative treatment existed.
| Organization | IDWeek 2026 Attendance |
|---|---|
UC Davis Health Sacramento, CA | |
Talk Tue Oct 20 1:35pm–2:10pm Sexually Transmitted Infections HIV, sexually transmitted infections and viral hepatitis Session Thu Oct 22 8:00am–9:00am Antifungal Prophylaxis in the Immunocompromised Host: Who, When and for How Long? Transplant and immunocompromised hostsAntimicrobials, resistance and stewardship Poster Thu Oct 22 12:15pm–1:30pm Long-Term Follow-Up of Study 32 (S32LTFU): A Retrospective Observational Study to Collect Long-Term Follow-Up Data from Patients in Study 32, an Open-Label Single-Arm Phase IIb Study of Olorofim as Treatment of Invasive Fungal Infections due to Lomentospora prolificans, Scedosporium spp., Aspergillus spp., and Other Resistant Fungi in Patients Lacking Suitable Alternative Treatment Options (NCT03583164). Session Thu Oct 22 3:15pm–4:30pm Talk Thu Oct 22 4:05pm–4:30pm Into the Unknown: Molds in Bronchiectasis Respiratory infections and COVID-19 Talk Fri Oct 23 10:55am–11:20am Session Fri Oct 23 3:15pm–4:30pm Big Beasts of Clinical Mycology Global and public healthTransplant and immunocompromised hosts Poster Sat Oct 24 12:15pm–1:30pm Clinical Characteristics and Outcomes of Osteoarticular Sporotrichosis: A Cohort Study Poster Sat Oct 24 12:15pm–1:30pm Routine vs Selective Echocardiography in Candidemia: A Systematic Review and Meta-Analysis, an MSG/ECMM Joint Initiative |
Instantly find 20 buyers from UC Davis Health
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction